CD8A and neoplasm: Based on the synergistic effect of Pam3 and mRNA triggering different TLR subclasses, the Pam-LNPs exhibited strong immune stimulation in cells and produced a large number of antigen-specific CD8+ T cells, which greatly improved the efficacy of the mRNA vaccine in tumor prevention.